Join to View Full Profile
1226 E Water StSyracuse, NY 13210
Phone+1 315-478-4185
Fax+1 315-478-0840
Dr. Pieczonka is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University at BuffaloResidency, Urology, 1999 - 2003- University at BuffaloResidency, Surgery, 1997 - 1999
- Jacobs School of Medicine and Biomedical Sciences at the University at BuffaloClass of 1997
Certifications & Licensure
NY State Medical License 2002 - 2026
American Board of Urology Urology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification MEDENT EMR/EHR, Community Computer Service, Inc., 2012
Clinical Trials
- Immune Monitoring Protocol in Men With Prostate Cancer Enrolled in a Clinical Trial of Sipuleucel-T Start of enrollment: 2012 Oct 01
- Positive Imaging Study for Distant Metastases in Patients With Castration-Resistant Prostate Cancer Start of enrollment: 2012 Jan 01
- PASCUAL (Prostate Assay Specific Clinical Utility at Launch) Study Start of enrollment: 2014 Sep 01
- Join now to see all
Publications & Presentations
PubMed
- TAR-200 for Bacillus Calmette-Guérin-Unresponsive High-Risk Non-Muscle-Invasive Bladder Cancer: Results From the Phase IIb SunRISe-1 Study.Siamak Daneshmand, Michiel S Van der Heijden, Joseph M Jacob, Felix Guerrero-Ramos, Martin Bögemann
Journal of Clinical Oncology. 2025-07-30 - Genomic prostate score and treatment selection in favourable intermediate-risk prostate cancer.Eric Margolis, Benjamin H Lowentritt, Christopher M Pieczonka, John P Bennett, Marina Pavlova
BJUI Compass. 2025-03-01 - Plain language summary: does enzalutamide treatment with or without leuprolide improve outcomes and affect quality of life in patients with high-risk biochemical recur...Stephen J Freedland, Martin Gleave, Ugo De Giorgi, Antti Rannikko, Christopher M Pieczonka
Future Oncology. 2025-02-01
Press Mentions
Groundbreaking AI-Powered Prostate Cancer Treatment Optimization Tool Now Available at Associated Medical Professionals of NY, a U.S. Urology Partners Affiliate in Central New YorkJuly 8th, 2025- ImmunityBio Announces First Dosing of Recombinant BCG (rBCG) in the U.S. And 60 Sites in the Process of LaunchingMarch 13th, 2025
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
